Preemie neurodevelopment (CME)

Keypoints:

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of CME² , Inc. ("cme² ") and Contemporary Pediatrics. cme² is accredited by the ACCME to provide continuing medical education for physicians. cme² designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Target audience: Pediatricians and primary care physicians

EDUCATIONAL OBJECTIVES

Resolution of conflict of interest
cme² has implemented a process to resolve conflicts of interest for each continuing medical education activity, to help ensure content validity, independence, fair balance,and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through a peer review process.

Unapproved/off-label use discussion
Faculty may discuss information about pharmaceutical agents, devices, or diagnostic products that are outside of FDA-approved labeling. This information is intended solely for CME and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Faculty are required to disclose any off-label discussion.

The rates of premature births (<37 weeks gestation) continue to increase. In the US, over 500,000 infants are born preterm each year, accounting for over 12.7% of all births.¹ The cost of caring for these children is estimated to be $26 billion a year, in part because infants born with very low birth weight (VLBW; <1,500 grams) are surviving more than ever before.¹ For this reason you are seeing, and are likely to see, more premature infants in your practice, whose care presents you with a variety of clinical challenges.